To further examine the effect of the cancer secretome on CAF activation, we isolated CAFs from CT-26-inoculated tumors, cultured these cells with CM from CT-26 stable cancer cells, and assessed CAF activities [20–22]. The gene discussed is DDX53; the disease is cancer.